Literature DB >> 16260618

Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer.

Chunling Yi1, Joseph H McCarty, Scott A Troutman, Matthew S Eckman, Roderick T Bronson, Joseph L Kissil.   

Abstract

The band 4.1 proteins are cytoskeletal proteins, harboring a conserved FERM domain highly homologous to the N-terminal FERM domain of ezrin, radixin, moesin, and merlin. Recently, a truncated form of the 4.1B protein, termed Dal-1, was identified in a screen as down regulated in adenocarcinoma of the lung and was mapped to chromosome 18p11.3, which is lost in 38% of primary non-small cell lung carcinoma tumors. Analysis of several meningiomas has shown that Dal-1 expression was lost in 76% of the tumors. To further elucidate the function of the 4.1B/Dal-1 gene in development and tumorigenesis we generated mice deficient for this allele. The 4.1B/Dal-1 null mice develop normally and are fertile. Rates of cellular proliferation and apoptosis in brain, mammary, and lung tissues from the 4.1B/Dal-1 null mice were indistinguishable from those seen with wild-type mice. Aging studies indicate that these mice do not have a propensity to develop tumors. Analysis of fibroblasts from these mice demonstrated that the growth characteristics and kinetics of these cells were not different from those of cells from the wild-type mice. These findings indicate that the 4.1B gene is not required for normal development and that 4.1B/Dal-1 does not function as a tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260618      PMCID: PMC1280276          DOI: 10.1128/MCB.25.22.10052-10059.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain.

Authors:  M Parra; P Gascard; L D Walensky; J A Gimm; S Blackshaw; N Chan; Y Takakuwa; T Berger; G Lee; J A Chasis; S H Snyder; N Mohandas; J G Conboy
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 2.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

3.  Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast.

Authors:  Y Tran; K Benbatoul; K Gorse; S Rempel; A Futreal; M Green; I Newsham
Journal:  Oncogene       Date:  1998-12-31       Impact factor: 9.867

4.  Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor.

Authors:  K Ye; D A Compton; M M Lai; L D Walensky; S H Snyder
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

5.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

6.  A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer.

Authors:  Y K Tran; O Bögler; K M Gorse; I Wieland; M R Green; I F Newsham
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

7.  Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation.

Authors:  Robin Kuns; Joseph L Kissil; Irene F Newsham; Tyler Jacks; David H Gutmann; Larry S Sherman
Journal:  Oncogene       Date:  2005-09-29       Impact factor: 9.867

8.  Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human.

Authors:  L L Peters; H U Weier; L D Walensky; S H Snyder; M Parra; N Mohandas; J G Conboy
Journal:  Genomics       Date:  1998-12-01       Impact factor: 5.736

9.  Isolation and mapping of human T-cell protein tyrosine phosphatase sequences: localization of genes and pseudogenes discriminated using fluorescence hybridization with genomic versus cDNA probes.

Authors:  C V Johnson; D E Cool; M B Glaccum; N Green; E H Fischer; A Bruskin; D E Hill; J B Lawrence
Journal:  Genomics       Date:  1993-06       Impact factor: 5.736

10.  Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities.

Authors:  Z T Shi; V Afzal; B Coller; D Patel; J A Chasis; M Parra; G Lee; C Paszty; M Stevens; L Walensky; L L Peters; N Mohandas; E Rubin; J G Conboy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

View more
  19 in total

1.  The cytoskeletal adaptor protein band 4.1B is required for the maintenance of paranodal axoglial septate junctions in myelinated axons.

Authors:  Elizabeth D Buttermore; Jeffrey L Dupree; JrGang Cheng; Xiuli An; Lino Tessarollo; Manzoor A Bhat
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Comprehensive characterization of protein 4.1 expression in epithelium of large intestine.

Authors:  Jingxin Zhang; Shaomin Yang; Chao An; Jie Wang; Hongxia Yan; Yumin Huang; Jinlei Song; Changcheng Yin; Anthony J Baines; Narla Mohandas; Xiuli An
Journal:  Histochem Cell Biol       Date:  2014-06-10       Impact factor: 4.304

3.  A 130-kDa protein 4.1B regulates cell adhesion, spreading, and migration of mouse embryo fibroblasts by influencing actin cytoskeleton organization.

Authors:  Jie Wang; Jinlei Song; Chao An; Wenji Dong; Jingxin Zhang; Changcheng Yin; John Hale; Anthony J Baines; Narla Mohandas; Xiuli An
Journal:  J Biol Chem       Date:  2013-12-31       Impact factor: 5.157

4.  Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.

Authors:  Dimitra Dafou; Barbara Grun; John Sinclair; Kate Lawrenson; Elizabeth C Benjamin; Estrid Hogdall; Susanne Kruger-Kjaer; Lise Christensen; Heidi M Sowter; Ahmed Al-Attar; Richard Edmondson; Stephen Darby; Andrew Berchuck; Peter W Laird; C Leigh Pearce; Susan J Ramus; Ian J Jacobs; Simon A Gayther
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

Review 5.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

6.  Protein 4.1R links E-cadherin/beta-catenin complex to the cytoskeleton through its direct interaction with beta-catenin and modulates adherens junction integrity.

Authors:  Shaomin Yang; Xinhua Guo; Gargi Debnath; Narla Mohandas; Xiuli An
Journal:  Biochim Biophys Acta       Date:  2009-04-17

7.  Band 4.1 proteins regulate integrin-dependent cell spreading.

Authors:  Youngsin Jung; Joseph H McCarty
Journal:  Biochem Biophys Res Commun       Date:  2012-09-06       Impact factor: 3.575

8.  The 4.1B cytoskeletal protein regulates the domain organization and sheath thickness of myelinated axons.

Authors:  Steven Einheber; Xiaosong Meng; Marina Rubin; Isabel Lam; Narla Mohandas; Xiuli An; Peter Shrager; Joseph Kissil; Patrice Maurel; James L Salzer
Journal:  Glia       Date:  2012-10-26       Impact factor: 7.452

Review 9.  Cell adhesion and signaling networks in brain neurovascular units.

Authors:  Joseph H McCarty
Journal:  Curr Opin Hematol       Date:  2009-05       Impact factor: 3.284

10.  Protein 4.1B suppresses prostate cancer progression and metastasis.

Authors:  Sunny Y Wong; Herbert Haack; Joseph L Kissil; Marc Barry; Roderick T Bronson; Steven S Shen; Charles A Whittaker; Denise Crowley; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.